Immunological evaluation of cytokine and anticytokine immunotherapy in vivo: what have we learnt?

Ann Rheum Dis. 1999 Mar;58(3):136-41. doi: 10.1136/ard.58.3.136.

Authors

C Jorgensen¹, F Apparailly, J Sany

Affiliation

¹ Immuno-rheumatology Department, CHU Lapeyronie, Montpellier, France.

No abstract available

Publication types

Review

MeSH terms

Antibodies, Monoclonal / therapeutic use
Arthritis, Rheumatoid / immunology
Arthritis, Rheumatoid / therapy
Autoimmune Diseases / immunology
Autoimmune Diseases / therapy*
Cytokines / antagonists & inhibitors
Cytokines / immunology
Cytokines / therapeutic use*
Humans
Immunotherapy / methods*
Interleukin-10 / therapeutic use
Interleukin-6 / antagonists & inhibitors
Receptors, Cytokine / antagonists & inhibitors*
Receptors, Interleukin-1 / antagonists & inhibitors
Recombinant Proteins / therapeutic use
Tumor Necrosis Factor-alpha / immunology

Substances

Antibodies, Monoclonal
Cytokines
Interleukin-6
Receptors, Cytokine
Receptors, Interleukin-1
Recombinant Proteins
Tumor Necrosis Factor-alpha
Interleukin-10